Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05321615 2023-10-25

Palpator

Phase NA Unknown

22 enrolled

Thoracic

Lung Neoplasms, Thoracic Neoplasms

NCT05988736 2023-08-14

Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients.

Phase NA Unknown

84 enrolled

Thoracic

Thoracic Diseases, Thoracic Neoplasms, Empyema, Pleural

NCT04235556 2022-05-13

PASSION

Unknown

1,800 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Personal Satisfaction, Prostatic Neoplasms, Stomach Neoplasms, Thoracic Neoplasms

NCT03521986 2022-05-11

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Phase 3 Unknown

100 enrolled

Thoracic

Mediastinal Neoplasms, Pain, Thoracic Neoplasms

NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Phase 2 Unknown

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

NCT04371796 2020-05-01

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

Phase 2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Phase 1/2 Unknown

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT02833467 2019-08-28

Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

Unknown

45 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

NCT03389256 2018-01-03

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Phase 2 Unknown

144 enrolled

Thoracic

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT03168048 2017-05-30

OPTIMISE-1

Phase NA Unknown

50 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Pelvic Neoplasms, Personal Satisfaction, Thoracic Neoplasms, Patient Satisfaction

NCT01913769 2013-08-01

Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan

Unknown

100 enrolled

Thoracic

Thoracic Neoplasms

NCT00631839 2008-10-07

Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury

Unknown

140 enrolled

Thoracic

Thoracic Neoplasms

Clinical Trials

ILST

Palpator

Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients.

PASSION

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

OPTIMISE-1

Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan

Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury